Ding Wang
Impact in
-
- Mesenchymal stem cell research
- Inflammatory Bowel Disease
-
- Cancer Cells and Metastasis
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 2
- Colorectal Cancer Treatments and Studies 2
- Pancreatic and Hepatic Oncology Research 2
-
- Lung Cancer Treatments and Mutations 4
- Advanced Breast Cancer Therapies 2
- Ferroptosis and cancer prognosis 1
- Renal cell carcinoma treatment 1
- Co-authors
- Chunlan Dong (1 shared paper)Xiaoguang Zhang (1 shared paper)Xiaojun Chen (1 shared paper)Weiting Du (1 shared paper)Jie Xu (1 shared paper)Zhongchao Han (1 shared paper)Weixian Chen (3 shared papers)Meng Liu (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)PLoS ONE (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Blood (1 paper)Journal of Multidisciplinary Healthcare (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ding Wang
21 papers receiving 264 citations
Peers
Comparison fields: 5 of 68
- Genetics 62
- Oncology 54
- Immunology 34
- Insect Science 21
- Hematology 12
Countries citing papers authored by Ding Wang
This map shows the geographic impact of Ding Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Wang more than expected).
Fields of papers citing papers by Ding Wang
This network shows the impact of papers produced by Ding Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Wang. The network helps show where Ding Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ding Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 88 | |
| 2 | 2014 | 36 | |
| 3 | 2014 | 26 | |
| 4 | 2021 | 17 | |
| 5 | 2013 | 16 | |
| 6 | 2019 | 14 | |
| 7 | 2016 | 10 | |
| 8 | 2021 | 9 | |
| 9 | 2016 | 9 | |
| 10 | 2020 | 7 | |
| 11 | 2018 | 7 | |
| 12 | 2023 | 7 | |
| 13 | 2024 | 6 | |
| 14 | 2015 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2025 | 2 | |
| 17 | 2014 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2020 | 1 |
About Ding Wang
Ding Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Epidemiology and Physiology, having authored 23 papers that have together received 267 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Cancer Treatment and Pharmacology (2 papers), Advanced Breast Cancer Therapies (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Autophagy in Disease and Therapy (2 papers), Ferroptosis and cancer prognosis (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Genetics (62 citations), Oncology (54 citations), Immunology (34 citations), Insect Science (21 citations) and Hematology (12 citations). Ding Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Chunlan Dong, Xiaoguang Zhang, Xiaojun Chen, Weiting Du, Jie Xu, Zhongchao Han, Weixian Chen, Meng Liu, Delin Zhu and Lu Liang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Cancer Chemotherapy and Pharmacology, Blood and Journal of Multidisciplinary Healthcare.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.